Analysts are more bearish after recent results, leading to lower revenue forecasts and a significant cut to earnings per share estimates. The consensus price target fell notably, with analysts not reassured by the latest results, leading to a lower estimate of Xinyi Glass Holdings' future valuation.
Xinyi Glass Holdings' decreasing ROCE and revenue drop, despite employing more capital, may suggest a loss in competitive advantage or market share. The flat stock trend over five years indicates investor disinterest.
The recent insider purchases and high level of insider ownership suggest insiders are quite bullish about Xinyi Glass Holdings. This significant ownership by insiders generally increases the chance that the company is run in the interest of all shareholders.
Despite Xinyi Glass Holdings' high earning outlook, its P/E ratio aligns with others, reflecting shareholders' skepticism towards their forecasts. The possibility of unstable earnings could contribute to this lower P/E ratio.
Given the decreases in ROCE and revenue despite increased capital deployment in the business, there are some reservations about Xinyi Glass Holdings' potential for growth going forward. Unless current trends are reversed, long-term performance might be negatively affected.
信義玻璃(ADR)股票討論區
專欄港股收評:恆生科技指數跌3%,醫藥、芯片、新能源板塊下挫
今日,港股全天呈下跌行情,市場情緒表現低迷,恆生科技指數大跌3.46%,恆指、$國企指數(800100.HK)$ 分別下跌1.71%和1.96%,恆指下挫近350點,三者齊刷月內新低價。
盤面上,大型科技股全線下跌,$美團-W(03690.HK)$ 、$京東集團-SW(09618.HK)$ 跌超4%,$快手-W(01024.HK)$ 、$小米集團-W(01810.HK)$ 、$百度集團-SW(09888.HK)$ 、$網易-S(09999.HK)$ 、$阿里巴巴-SW(09988.HK)$ 皆跌超3%;
生物醫藥股領跌市場,藥明康德重挫超10%;此前消息稱拜登政府欲限制美企對華投資,半導體股連續下跌,且午後跌幅擴大明顯;特斯拉概念股、鋰電池股、光伏股等新能源股跌幅靠前,濠賭股、軍工...
CIMB: Xinyi Glass – Add Target Price HK$18.74
$信義玻璃(00868.HK)$
暫無評論